4//SEC Filing
SIGMA TAU FINANZIARIA SPA 4
Accession 0001140361-10-026302
CIK 0000812796other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:57 PM ET
Size
63.3 KB
Accession
0001140361-10-026302
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
SIGMA TAU FINANZIARIA SPA
10% Owner
Transactions
- Other
Common Stock Warrant (right to buy)
2010-06-18+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2010-06-18Exp: 2015-06-18→ Common Stock (5,165,148 underlying) - Purchase
Common Stock
2010-06-18$0.20/sh+8,608,580$1,764,759→ 54,227,816 total(indirect: Indirect)
Sigma-Tau America S.A.
10% Owner
Transactions
- Purchase
Common Stock
2010-06-18$0.20/sh+8,608,580$1,764,759→ 54,227,816 total(indirect: Indirect) - Other
Common Stock Warrant (right to buy)
2010-06-18+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2010-06-18Exp: 2015-06-18→ Common Stock (5,165,148 underlying)
Sigma-Tau Pharmaceuticals, Inc.
10% Owner
Transactions
- Purchase
Common Stock
2010-06-18$0.20/sh+8,608,580$1,764,759→ 54,227,816 total(indirect: Indirect) - Other
Common Stock Warrant (right to buy)
2010-06-18+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2010-06-18Exp: 2015-06-18→ Common Stock (5,165,148 underlying)
SIGMA TAU INTERNATIONAL SA
10% Owner
Transactions
- Purchase
Common Stock
2010-06-18$0.20/sh+8,608,580$1,764,759→ 54,227,816 total(indirect: Indirect) - Other
Common Stock Warrant (right to buy)
2010-06-18+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2010-06-18Exp: 2015-06-18→ Common Stock (5,165,148 underlying)
Footnotes (3)
- [F1]Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. ("Pharmaceuticals"). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. ("America"). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. ("International"). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A.
- [F2]This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals' purchase of 8,608,580 shares of common stock on June 18, 2010.
- [F3]The expiration date of the warrant may be accelerated at the Issuer's option if the Issuers's common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended.
Issuer
SOLIGENIX, INC.
CIK 0000812796
Entity typeother
Related Parties
1- filerCIK 0001092601
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:57 PM ET
- Size
- 63.3 KB